Categories AlphaGraphs, Earnings, Health Care
Infographic: Key numbers from Johnson & Johnson (JNJ) Q2 2020 earnings announcement
Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today.
Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell 35% to $3.6 billion, or $1.36 per share. Adjusted EPS dropped 35% to $1.67.
The company raised its guidance for the full year of 2020. Reported sales are estimated to come in the range of $79.9-81.4 billion and adjusted EPS is expected to be $7.75-7.95.
Check this space for the transcript of Johnson & Johnson Q2 2020 earnings conference call
Past Performance
Most Popular
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with